Summit Partners invests in cancer diagnostics company
ApoCell, a molecular diagnostics laboratory that analyses the effectiveness of new compounds for the world’s leading pharmaceutical and biotechnology companies, has received an investment from growth equity investor Summit Partners. The investment will be used to fund ApoCell’s organic growth initiatives and continued development of the company’s technology platforms. “The